Mar 30, 2026
India’s NDCT Amendment Rules 2026: Major Regulatory Overhaul
New rules effective March 7, 2026 cut approval timelines from 90 to 45 days. Prior intimation replaces licenses for low-risk…
Read More
Mar 23, 2026
NDPS Act: Limited 2026 Updates Signal Regulatory Stability
Recent searches reveal minimal NDPS notifications in Q1 2026, while related pharmaceutical regulations show active enforcement. Key compliance insights.
Read More
Mar 22, 2026
CDSCO New 2026 Rules: Application Rejections & IVD Import Guide
CDSCO threatens rejection of 2+ year pending applications by Feb 14, 2026. New IVD import guidance and cosmetic enforcement actions…
Read More
Feb 26, 2026
CDSCO Circular (23–24 February 2026)
Key highlights from the CDSCO circular on “Testing of drugs for grant of permissions for import/manufacture of New Drug for…
Read More
Feb 23, 2026
Highlights of CDSCO Notification dated 16.02.2026
G.S.R. 135(E) – Changes to the Drugs Rules On February 16, 2026, the Central Drugs Standard Control Organization (CDSCO) rolled…
Read More
Feb 4, 2026
Trusted Regulatory Consultants in India for Business Compliance
Let’s be real: in today’s business world, you can’t just ignore compliance. It’s not a box to tick—it’s something you’ve…
Read More
Feb 4, 2026
Highlights and benefits of the recent U.S.–India trade agreement-Accredited Consultant Private Limited
Highlights and benefits of the recent U.S.–India trade agreement, with a focus on what it does (including tariff reductions) and…
Read More
Feb 3, 2026
India–EU Free Trade Agreement: What It Means for Business
India-EU Free Trade Agreement — The “Mother of All Deals” Big news on the trade front: On January 27, 2026,…
Read More
Jan 5, 2026
BIS Registration Consultant Noida
Noida’s business scene is changing fast, and if you want your products to hit the market without hiccups, you need…
Read More